Class · 2 published
Dual or triple agonist
| Name | Class | Regulatory status | Evidence grade | Access routes | Status checked |
|---|---|---|---|---|---|
| Retatrutide | Dual or triple agonist | investigationalchecked | moderate-human | Clinical trial | |
| Tirzepatide | Dual or triple agonist | fda-approvedchecked | strong-human | Approved product, Lawful compounding |